Comparing preference for and use of medication abortion in Texas after policy changes in 2014 and 2018
Authors:
- 5 December 2022
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 119, 109912
Abstract
No abstract availableKeywords
Funding Information
- Susan Thompson Buffett Foundation
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
This publication has 13 references indexed in Scilit:
- Impact of Clinic Closures on Women Obtaining Abortion Services After Implementation of a Restrictive Law in TexasAmerican Journal of Public Health, 2022
- Rebound of medication abortion in Texas following updated mifepristone labelContraception, 2019
- Women’s reasons for choosing abortion method: A systematic literature reviewScandinavian Journal of Public Health, 2017
- Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort StudyPLOS Medicine, 2016
- A New Label for MifepristoneNew England Journal of Medicine, 2016
- Change in abortion services after implementation of a restrictive law in TexasContraception, 2014
- Determinants of demand: method selection and provider preference among US women seeking abortion servicesContraception, 2008
- Women's perceptions on medical abortionContraception, 2006
- Acceptability and Feasibility of Early Pregnancy Termination by Mifepristone-Misoprostol: Results of a Large Multicenter Trial in the United StatesArchives of Family Medicine, 1998
- Acceptability of Medical Abortion in Early PregnancyFamily Planning Perspectives, 1995